Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats.

Source:http://linkedlifedata.com/resource/pubmed/id/1484155

Download in:

View as

General Info

PMID
1484155